Archemix Corp.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Archemix Corp..The latest application filed is for "anti-thrombin aptamer formulations and methods for use".

Company Profile

0.15.4

Archemix Corp. - Cambridge MA
Archemix Corp. -
Archemix Corporation - Cambridge MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Methods of separating biopolymer conjugated molecules from unconjugated molecules Grant 8,207,298 - Hatala , et al. June 26, 2	2012-06-26
Materials and methods for the generation of fully 2'-modified nucleic acid transcripts Grant 8,105,813 - Diener , et al. January 31, 2	2012-01-31
Materials and methods for the generation of transcripts comprising modified nucleotides Grant 8,101,385 - Cload , et al. January 24, 2	2012-01-24
Anti-thrombin Aptamer Formulations And Methods For Use App 20110275701 - Hutabarat; Renta	2011-11-10
Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics Grant 8,039,443 - Grate , et al. October 18, 2	2011-10-18
Aptamers that bind thrombin with high affinity Grant 7,998,939 - Diener , et al. August 16, 2	2011-08-16
Aptamers to von Willebrand factor and their use as thrombotic disease therapeutics Grant 7,998,940 - Diener , et al. August 16, 2	2011-08-16
Regulated aptamer therapeutics Grant 7,960,102 - Epstein , et al. June 14, 2	2011-06-14
Aptamer therapeutics useful in the treatment of complement-related disorders Grant 7,803,931 - Benedict , et al. September 28, 2	2010-09-28
Stabilized aptamers to PSMA and their use as prostate cancer therapeutics Grant 7,767,803 - Diener , et al. August 3, 2	2010-08-03
Solid Support Reagents for Synthesis App 20100041866 - Hatala; Paul J. ; et al.	2010-02-18
Aptamers to von Willebrand Factor and their use as thrombotic disease therapeutics Grant 7,589,073 - Diener , et al. September 15, 2	2009-09-15
Aptamer therapeutics useful in the treatment of complement-related disorders Grant 7,579,456 - Benedict , et al. August 25, 2	2009-08-25
Nucleic acid ligands specific to immunoglobulin E and their use as atopic disease therapeutics Grant 7,579,450 - Burmeister , et al. August 25, 2	2009-08-25
vWF aptamer formulations and methods for use App 20090203766 - Gilbert; James ; et al.	2009-08-13
Aptamers to von Willebrand Factor and their use as thrombotic disease therapeutics Grant 7,566,701 - Diener , et al. July 28, 2	2009-07-28
Aptamers to von Willebrand factor and their use as thrombotic disease therapeutics App 20090149643 - Diener; John L. ; et al.	2009-06-11
Aptamer therapeutics useful in the treatment of complement-related disorders Grant 7,538,211 - Benedict , et al. May 26, 2	2009-05-26
Nucleic acid sensor molecules and methods of using same Grant 7,125,660 - Stanton , et al. October 24, 2	2006-10-24

Company Registrations

NCAGE Code	1YCN5	ARCHEMIX CORP.
CAGE Code	1YCN5	ARCHEMIX CORP.
SEC	0001143527	Archemix Corp.

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.